We examined whether the effect of Y-26763, an ATP-sensitive potassium
channel opener, on cerebral blood how is altered in stroke-prone spont
aneously hypertensive rats (SHRSP) and, if altered, whether long-term
antihypertensive treatment with cilazapril, an angiotensin-converting
enzyme inhibitor, is capable of preventing the change. Cerebral blood
flow during intracarotid infusion of Y-26763 was measured in anestheti
zed SHRSP and normotensive Wistar-Kyoto rats (WKY) as control. Y-26763
increased cerebral blood flow in a dose-dependent manner in WKY, and
glibenclamide, a selective inhibitor of ATP-sensitive potassium channe
ls, inhibited the Y-26763-induced increase in cerebral blood flow. In
contrast, the response to Y-26763 in SHRSP was significantly impaired
compared with that in WKY. Antihypertensive treatment with cilazapril
lowered blood pressure toward normal and prevented the impaired respon
se in cerebral blood flow to Y-26763 in SHRSP. These findings suggest
that (1) ATP-sensitive potassium channels contribute to the regulation
of cerebral blood flow in rats, (2) the response to an ATP-sensitive
potassium channel opener is markedly diminished in hypertensive rats,
and (3) the altered response to an ATP-sensitive potassium channel ope
ner during chronic hypertension can be prevented by long-term antihype
rtensive treatment.